Regenerative medicine company

I supported pre-IND preparation for a cell therapy and device combination product. I reviewed existing protocols, converted them into a consistent cGMP-compliant format, and established a version control system to manage the documentation going forward. I also reviewed FDA documentation and developed a donor screening survey for umbilical cord and blood donors.